An advisory committee of the Food and Drug Administration of the United States (FDA, in English) recommended this Thursday to be approved urgently Pfizer’s COVID-19 vaccine, a key step in its distribution to millions of Americans.
The members of what is known as the FDA Vaccine and Biological Products Advisory Committee voted 17 in favor, 4 against and 1 abstention for the vaccine to be administered to all those individuals with at least 16 years old, age from which Pfizer has demonstrated that its application safe.
The vote in favor of the committee it is not binding And it does not mean that the vaccine was automatically given the green light, as it is up to the FDA to make the final decision.
In an interview with NBC on Thursday, FDA Commissioner Stephen Hahn reaffirmed that vaccine approval will come “very soon” after the evaluation of the expert committee, although it did not specify the exact date. After the vote, CNN said that approval could come this Thursday or Friday.
If the FDA decides to approve Pfizer’s vaccine, the US will become the fifth country in the world to give the go-ahead to that remedy after United Kingdom, Bahrain, Canada and Saudi Arabia.
One of the stellar interventions on the committee was that of Pfizer’s head of vaccine research and development, Kathrin Jansen, who defended that immunization is the only way known so far to fight the virus, as no treatment has proven to be completely effective.
“No one is safe from this disease. It has become very clear, especially now with the increase in cases around the world, and also in the US, that we need a vaccine to end this devastating pandemic, “he said.
In contrast to Pfizer’s confidence, Nissa Shaffi of the National League of Consumers (LNC) said concern about allergic reactions that suffered two vaccinated people on Tuesday in the United Kingdom, something that has led the British authorities to ask severe allergies not to be immunized.
“We ask the FDA to heed these warnings and to continue to play an important role in the collaboration and distribution of the vaccine to avoid any inconvenience “, Shaffi requested.
Pfizer’s vaccine approval could come as the United States records on average more than 200,000 daily cases and about 3,000 deaths every 24 hours.
The most recent data from Johns Hopkins University indicates that 15,550,786 people have been infected in the United States and 291,754 have died, more than in any other country in the world.